 | Matinas Biopharma Holdings, Inc | |||
| ASE : MTNB || Location: United States | ||||
$0.18-0.0 (-0.11%) |
0.52 M | 0.18 - 0.19 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 3.275 M |
| March 15, 2024 | 1.322 M |
| Feb. 29, 2024 | 1.470 M |
| Feb. 15, 2024 | 1.196 M |
| Jan. 31, 2024 | 1.422 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.03 | -0.02 | 34.64% |
| 09/30/2023 | -0.03 | -0.03 | 1.96% |
| 06/30/2023 | -0.03 | -0.03 | 1.96% |
| 03/31/2023 | -0.03 | -0.03 | 1.96% |
| 12/31/2022 | -0.03 | -0.02 | 26.47% |
MTNB Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 250.816M | Shares Float | 211.957M |
| Short Float | 3.275M | Market Cap | 45.15M |
| Institution ownership | 10.43% | Insider ownership | 2.525% |
| Earnings Date | 05/08/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.11 | Forward EPS | -0.10 |